Xavier Ayrignac

6.8k total citations
95 papers, 1.7k citations indexed

About

Xavier Ayrignac is a scholar working on Neurology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Xavier Ayrignac has authored 95 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Neurology, 36 papers in Pathology and Forensic Medicine and 17 papers in Molecular Biology. Recurrent topics in Xavier Ayrignac's work include Multiple Sclerosis Research Studies (34 papers), Peripheral Neuropathies and Disorders (21 papers) and Systemic Lupus Erythematosus Research (12 papers). Xavier Ayrignac is often cited by papers focused on Multiple Sclerosis Research Studies (34 papers), Peripheral Neuropathies and Disorders (21 papers) and Systemic Lupus Erythematosus Research (12 papers). Xavier Ayrignac collaborates with scholars based in France, United States and Switzerland. Xavier Ayrignac's co-authors include Pierre Labauge, Clarisse Carra‐Dallière, Elisabeth Tournier‐Lasserve, Nicolas Menjot de Champfleur, Françoise Bergametti, Gwénola Boulday, Florence Riant, Pierre Labauge, Caroline Arquizan and Mahmoud Charif and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Brain.

In The Last Decade

Xavier Ayrignac

92 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Ayrignac France 22 814 428 343 293 251 95 1.7k
Ananth K. Vellimana United States 24 557 0.7× 207 0.5× 195 0.6× 175 0.6× 161 0.6× 65 1.4k
Antonino Germanò Italy 26 542 0.7× 203 0.5× 412 1.2× 498 1.7× 252 1.0× 117 2.1k
Jean‐Philippe Camdessanché France 25 1.5k 1.8× 249 0.6× 300 0.9× 106 0.4× 463 1.8× 101 2.0k
Tatsuo Kohriyama Japan 27 988 1.2× 222 0.5× 592 1.7× 332 1.1× 543 2.2× 104 2.2k
Efstathios Papavassiliou United States 20 673 0.8× 145 0.3× 492 1.4× 168 0.6× 332 1.3× 62 2.0k
Jianhua Yan China 18 875 1.1× 248 0.6× 615 1.8× 300 1.0× 177 0.7× 107 1.9k
Shigeru Nishizawa Japan 31 1.7k 2.1× 279 0.7× 751 2.2× 518 1.8× 366 1.5× 174 3.6k
Atay Vural Türkiye 14 462 0.6× 165 0.4× 259 0.8× 265 0.9× 240 1.0× 47 1.3k
Domenico La Torre Italy 23 313 0.4× 265 0.6× 387 1.1× 245 0.8× 221 0.9× 67 1.5k
Zoltán Patay United States 25 456 0.6× 135 0.3× 462 1.3× 306 1.0× 192 0.8× 105 2.0k

Countries citing papers authored by Xavier Ayrignac

Since Specialization
Citations

This map shows the geographic impact of Xavier Ayrignac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Ayrignac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Ayrignac more than expected).

Fields of papers citing papers by Xavier Ayrignac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Ayrignac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Ayrignac. The network helps show where Xavier Ayrignac may publish in the future.

Co-authorship network of co-authors of Xavier Ayrignac

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Ayrignac. A scholar is included among the top collaborators of Xavier Ayrignac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Ayrignac. Xavier Ayrignac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sèze, J. de, Chiara Zecca, Giovanni Castelnovo, et al.. (2025). European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?. Multiple Sclerosis Journal - Experimental Translational and Clinical. 11(1). 3120685010–3120685010. 2 indexed citations
2.
Carmona, Sylvie, Thierry Vincent, Pierre Labauge, et al.. (2024). TWEAK and TNFɑ Pro-inflammatory Soluble Cytokines and their Specific Autoantibodies Secretion in Multiple Sclerosis Patients. Inflammation. 48(4). 2494–2502.
3.
Chaussenot, Annabelle, Xavier Ayrignac, Nicolas Chatron, et al.. (2024). Loss of heterozygosity in CCM2 cDNA revealing a structural variant causing multiple cerebral cavernous malformations. European Journal of Human Genetics. 32(7). 876–878. 2 indexed citations
4.
Gélisse, Philippe, Jean‐Jacques Tudesq, Pierre Labauge, et al.. (2023). Frontal Intermittent Rhythmic Delta Activity Is a Useful Diagnostic Tool of Neurotoxicity After CAR T-Cell Infusion. Neurology Neuroimmunology & Neuroinflammation. 10(4). 10 indexed citations
5.
Pique, Julie, Adil Maarouf, Xavier Ayrignac, et al.. (2022). Time to steroids impacts visual outcome of optic neuritis in MOGAD. Journal of Neurology Neurosurgery & Psychiatry. 94(4). 309–313. 18 indexed citations
6.
Deverdun, Jérémy, Xavier Ayrignac, Clarisse Carra‐Dallière, et al.. (2021). Cerebral Vasoreactivity as an Indirect MRI Marker of White Matter Tracts Alterations in Multiple Sclerosis. Brain Topography. 34(2). 245–255. 2 indexed citations
7.
Lehmann, Sylvain, Julien Dumurgier, Xavier Ayrignac, et al.. (2020). Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals. Alzheimer s Research & Therapy. 12(1). 123–123. 40 indexed citations
8.
Masingue, Marion, Timothée Lenglet, Cyril Goizet, et al.. (2020). Natural History of Adult Patients with GM2 Gangliosidosis. Annals of Neurology. 87(4). 609–617. 41 indexed citations
9.
Bigaut, Kévin, Charles Paul Lambert, Laurent Kremer, et al.. (2020). Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal. 27(2). 232–238. 5 indexed citations
10.
López-Sánchez, Uriel, Gaël Nicolas, Miranda Wilson, et al.. (2020). Interplay between primary familial brain calcification-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis. Journal of Biological Chemistry. 295(28). 9366–9378. 50 indexed citations
11.
Ayrignac, Xavier, Clarisse Carra‐Dallière, Mahmoud Charif, et al.. (2020). Kappa free light chain in multiple sclerosis: higher sensitivity but lower specificity than oligoclonal bands. (585). Neurology. 94(15_supplement).
12.
Shor, Natalia, Romain Deschamps, Élisabeth Maillart, et al.. (2020). MRI characteristics of MOG-Ab associated disease in adults: An update. Revue Neurologique. 177(1-2). 39–50. 14 indexed citations
13.
Ayrignac, Xavier, Philippe‐Antoine Bilodeau, Alexandre Prat, et al.. (2019). Assessing the risk of multiple sclerosis disease-modifying therapies. Expert Review of Neurotherapeutics. 19(7). 695–706. 8 indexed citations
14.
Ayrignac, Xavier, Clarisse Carra‐Dallière, Mikaël Cohen, et al.. (2018). Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases. Multiple Sclerosis and Related Disorders. 28. 109–116. 8 indexed citations
15.
Dunet, Vincent, Jérémy Deverdun, Emmanuelle Le Bars, et al.. (2017). MRI volumetric morphometry in vascular parkinsonism. Journal of Neurology. 264(7). 1511–1519. 9 indexed citations
16.
Ayrignac, Xavier, Gaël Nicolas, Clarisse Carra‐Dallière, Didier Hannequin, & Pierre Labauge. (2017). Brain Calcifications in Adult-Onset Genetic Leukoencephalopathies. JAMA Neurology. 74(8). 1000–1000. 14 indexed citations
17.
Lebrun‐Frénay, Christine, Mikaël Cohen, Lydiane Mondot, Xavier Ayrignac, & Pierre Labauge. (2017). A Case Report of Solitary Sclerosis: This is Really Multiple Sclerosis. Neurology and Therapy. 6(2). 259–263. 9 indexed citations
18.
Dunet, Vincent, Jérémy Deverdun, Emmanuelle Le Bars, et al.. (2016). Cognitive Impairment and Basal Ganglia Functional Connectivity in Vascular Parkinsonism. American Journal of Neuroradiology. 37(12). 2310–2316. 13 indexed citations
19.
Collombier, Laurent, Giovanni Castelnovo, Mahmoud Charif, et al.. (2014). Contribution Of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) In Myelitis: A Multicentre Cohort Of 13 Cases (P5.182). Neurology. 82(10_supplement). 1 indexed citations
20.
Carra‐Dallière, Clarisse, Xavier Ayrignac, Dimitri Renard, et al.. (2013). Isolated Lacunar Infarct: An Early Clinical Presentation of CADASIL?. Cerebrovascular Diseases. 35(3). 298–299. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ananth K. Vellimana Breakdown of academic impact, for papers by Antonino Germanò Breakdown of academic impact, for papers by Jean‐Philippe Camdessanché Breakdown of academic impact, for papers by Tatsuo Kohriyama Breakdown of academic impact, for papers by Efstathios Papavassiliou Breakdown of academic impact, for papers by Jianhua Yan Breakdown of academic impact, for papers by Shigeru Nishizawa Breakdown of academic impact, for papers by Atay Vural Breakdown of academic impact, for papers by Domenico La Torre Breakdown of academic impact, for papers by Zoltán Patay
Rankless by CCL
2026